The B.R. Goyal IPO presents an attractive investment opportunity with a book-built issue worth ₹33.80 crores. It comprises 41.73 lakh fresh shares aimed at raising growth capital for the company’s expansion and operations, making it appealing to investors seeking liquidity and potential returns.
The subscription window runs from 10 January 2025 to 14 January 2025, offering a limited period to invest. With a price band of ₹77 to ₹81 per share, investors can bid flexibly. Applications are accepted in lots of 1,600 shares, requiring a minimum investment of ₹1,29,600, while HNIs must apply for at least 2 lots (3,200 shares), amounting to ₹2,59,200. The IPO is set to list on NSE SME on 17 January 2025, with its structured approach and competitive pricing expected to attract both retail and institutional investors.
Check the current GMP of Sat Kartar Shopping IPO
Refer to Sat Kartar Shopping IPO RHP for detailed information.
Table of content
- Sat Kartar Shopping IPO Good or Bad, should apply?
- Sat Kartar Shopping IPO Details
- Sat Kartar Shopping IPO Lot Size calculator
- Sat Kartar Shopping IPO Distribution
- About Sat Kartar Shopping Company
- Sat Kartar Shopping Company Finances
- Sat Kartar Shopping IPO Prospectus
- Read our other articles(IPO Insights)
Sat Kartar Shopping IPO Good or Bad, should apply?
Sat Kartar Shopping Limited, an Ayurveda healthcare company, offers natural wellness solutions targeting therapeutic and lifestyle needs. With a strong focus on promoting healthier living, the company has demonstrated significant growth in both revenue and profitability. Given the company’s attractive financial performance, applying for this IPO could offer potential for good listing gains, especially for those looking for short-term returns.
For retail investors aiming for short-term listing gains, it’s recommended to apply based on the third-day GMP (Grey Market Premium). This provides insight into the likely listing price and market demand, giving investors an edge in predicting the IPO’s potential performance. Additionally, for long-term investment, Sat Kartar’s focus on holistic health and expanding product portfolio makes it an appealing option for those looking to invest in the growing wellness sector.
Sat Kartar Shopping IPO Details
| IPO Date | January 10, 2025 to January 14, 2024 | ||
| Listing Date | 17 January, 2025 | ||
| Face value | ₹10 per share | ||
| Price band | ₹77 to ₹81 per share | ||
| Lot size | 1,600 Shares | ||
| Total Issue Size | 41,72,800 shares (aggregating up to ₹33.80 Cr) | ||
| Fresh Issue | 41,72,800 shares (aggregating up to ₹33.80 Cr) | ||
| Offer for Sale | 0 | ||
| Issue Type | Fixed Price Issue IPO | ||
| Listing At | NSE SME | ||
| Share Holding Post Issue | 1,57,44,876 shares | ||
| Market Maker Portion | 2,33,600 shares Prabhat Financial Services Ltd. |
Sat Kartar Shopping IPO Lot Size calculator
| Application | Lots | Share | Amount |
| Retail (Min) | 1 | 1,600 | ₹1,29,600 |
| Retail (Max) | 1 | 1,600 | ₹1,29,600 |
| HNI (Min) | 2 | 3,200 | ₹2,59,200 |
Sat Kartar Shopping IPO Distribution
| Investor Category | Shares Offered |
| QIB Shares Offered | No more than 50% of the Net Issue |
| Retail Shares Offered | Not less than 35% of the Net Issue |
| NII (HNI) Shares Offered | Not less than 15% of the Net Issue |
About Sat Kartar Shopping Company
Established in June 2012, Sat Kartar Shopping Limited specialises in Ayurveda-based healthcare, offering natural wellness products to promote a balanced and healthier lifestyle.
The company caters directly to consumers by providing a wide range of Ayurvedic remedies and lifestyle solutions. Their products are available through multiple channels, including their official website, popular e-commerce platforms, television campaigns, and digital advertisements on Google and Meta.
Product Categories:
- Therapeutic Solutions for Specific Health Concerns: The company focuses on niche areas addressing particular health challenges, such as addiction recovery, personal care, and overall wellness. Flagship products include Addiction Killer and Liv Muztang.
- Lifestyle-Driven Wellness Products: They also develop remedies targeting lifestyle-related health conditions such as diabetes, joint pain, piles, and more.
Expanding its portfolio, the company is venturing into products for slimming, hair care, gut health, PCOD, and mental well-being.
As of 30 November 2024, the company employs 1,122 professionals across various departments.
Key Strengths:
Streamlined logistics and distribution systems
- Nationwide brand presence
- Asset-light operational model
- Robust digital media footprint
- Customer anonymity in sensitive categories
- In-house R&D backed by clinical trials
Sat Kartar Shopping Company Finances
Over the past four financial years, the company has demonstrated significant growth in key financial metrics. Total assets have grown steadily, rising from ₹1,239.33 lakhs in FY21 to ₹3,117.07 lakhs in FY24, showcasing a compound growth trajectory. Revenue performance has been robust, peaking at ₹12,810.96 lakhs in FY23 before settling at ₹10,955.26 lakhs in FY24. Profit after tax has followed a similar upward trend, increasing from ₹138.69 lakhs in FY21 to ₹589.71 lakhs in FY24. The company’s net worth has also expanded substantially, climbing from ₹76.87 lakhs in FY21 to ₹1,728.14 lakhs in FY24, supported by a consistent build-up in reserves and surplus, which reached ₹570.93 lakhs in FY24. Despite fluctuations in borrowing levels, with a peak of ₹814.75 lakhs in FY21, the company has managed to reduce debt to ₹402.63 lakhs in FY24, reflecting improved financial health and efficient capital management.
Amount in ₹ Lakhs
| Period Ended | 15 Dec 2024 | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 |
| Assets | 3,117.07 | 2,175.43 | 1,471.2 | 1,239.33 |
| Total Borrowings | 402.63 | 177.99 | 375.24 | 814.75 |
| Revenue | 10,955.26 | 12,810.96 | 8,297.74 | 5,230.75 |
| Profit after tax | 589.71 | 630.55 | 250.61 | 138.69 |
| Net Worth | 1,728.14 | 943.33 | 327.48 | 76.87 |
| Reserves and Surplus | 570.9 | 663.33 | 257.48 | 6.87 |
Sat Kartar Shopping IPO Prospectus
Read our other articles(IPO Insights)
- FII DII Selling Data, 27 January 2025
- FII DII Selling Data, 24 January 2025
- FII DII Selling Data, 23 January 2025
- FII DII Selling Data, 22 January 2025
- CLN Energy IPO GMP today – Apply or Not
Leave a Reply